CLB Core Laboratories N V

Price (delayed)

$33.81

Market cap

$1.57B

P/E Ratio

80.5

Dividend/share

$0.04

EPS

$0.42

Enterprise value

$1.82B

Sector: Energy
Industry: Oil & Gas Equipment & Services

Highlights

Core Laboratories N V's EPS has soared by 140% YoY and by 119% from the previous quarter
CLB's net income has soared by 140% year-on-year and by 119% since the previous quarter
The stock's price to earnings (P/E) is 53% more than its 5-year quarterly average of 52.5
CLB's gross profit is down by 41% year-on-year and by 12% since the previous quarter

Key stats

What are the main financial stats of CLB
Market
Shares outstanding
46.31M
Market cap
$1.57B
Enterprise value
$1.82B
Valuations
Price to earnings (P/E)
80.5
Price to book (P/B)
10.62
Price to sales (P/S)
3.45
EV/EBIT
42.05
EV/EBITDA
28.61
EV/Sales
4.1
Earnings
Revenue
$443.25M
EBIT
$43.21M
EBITDA
$63.5M
Free cash flow
$33.97M
Per share
EPS
$0.42
Free cash flow per share
$0.75
Book value per share
$3.18
Revenue per share
$9.81
TBVPS
$10.55
Balance sheet
Total assets
$584.45M
Total liabilities
$438.4M
Debt
$279.16M
Equity
$141.88M
Working capital
$100.28M
Liquidity
Debt to equity
1.97
Current ratio
2.17
Quick ratio
1.34
Net debt/EBITDA
3.96
Margins
EBITDA margin
14.3%
Gross margin
22.4%
Net margin
4.3%
Operating margin
9.9%
Efficiency
Return on assets
3.2%
Return on equity
22%
Return on invested capital
6.4%
Return on capital employed
8.7%
Return on sales
9.7%
Dividend
Dividend yield
0.12%
DPS
$0.04
Payout ratio
9.5%

CLB stock price

How has the Core Laboratories N V stock price performed over time
Intraday
6.19%
1 week
19.98%
1 month
19.68%
1 year
107.55%
YTD
27.54%
QTD
17.44%

Financial performance

How have Core Laboratories N V's revenue and profit performed over time
Revenue
$443.25M
Gross profit
$99.46M
Operating income
$43.79M
Net income
$18.89M
Gross margin
22.4%
Net margin
4.3%
The operating margin has soared by 163% from the previous quarter
CLB's net margin has soared by 160% YoY and by 122% from the previous quarter
Core Laboratories N V's operating income has surged by 157% QoQ
CLB's net income has soared by 140% year-on-year and by 119% since the previous quarter

Growth

What is Core Laboratories N V's growth rate over time

Valuation

What is Core Laboratories N V stock price valuation
P/E
80.5
P/B
10.62
P/S
3.45
EV/EBIT
42.05
EV/EBITDA
28.61
EV/Sales
4.1
Core Laboratories N V's EPS has soared by 140% YoY and by 119% from the previous quarter
The stock's price to earnings (P/E) is 53% more than its 5-year quarterly average of 52.5
CLB's equity has soared by 116% YoY and by 98% from the previous quarter
The P/B is 53% below the 5-year quarterly average of 22.5 and 15% below the last 4 quarters average of 12.5
CLB's price to sales (P/S) is 73% higher than its last 4 quarters average of 2.0 but 34% lower than its 5-year quarterly average of 5.2
The company's revenue fell by 32% YoY and by 9% QoQ

Efficiency

How efficient is Core Laboratories N V business performance
The return on equity has surged by 173% year-on-year and by 115% since the previous quarter
Core Laboratories N V's ROS has soared by 161% from the previous quarter
The return on invested capital has surged by 159% since the previous quarter
The ROA has soared by 151% YoY and by 120% from the previous quarter

Dividends

What is CLB's dividend history
DPS
$0.04
Dividend yield
0.12%
Payout ratio
9.5%
Recent dividends

Financial health

How did Core Laboratories N V financials performed over time
The total assets is 33% greater than the total liabilities
The quick ratio has increased by 24% QoQ and by 3.1% YoY
The total liabilities has decreased by 24% YoY and by 11% from the previous quarter
CLB's debt is 97% more than its equity
CLB's equity has soared by 116% YoY and by 98% from the previous quarter
The debt to equity has shrunk by 65% YoY and by 57% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.